A POTENTIAL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a formidable brain tumor known for its rapid growth and insensitivity to conventional treatments. Studies are constantly underway to identify new therapeutic strategies, and recently, a unique biomarker named LCA168 has emerged as a potential target for glioblastoma treatment. LCA168 is a protein that is overexpressed in glioblasto